| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.56B | +4.1% |
| Cost of Revenue | $1.34B | +5.4% |
| Gross Profit | $1.22B | +2.8% |
| R&D Expense | $76.5M | +12.8% |
| SG&A Expense | $833.4M | +4.0% |
| Operating Income | $299.4M | -1.6% |
| Pre-tax Income | $239.5M | -4.1% |
| Income Tax | $52.4M | +9.5% |
| Net Income | $188.5M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $217.5M | -0.4% |
| Inventory | $608.6M | +5.7% |
| Current Assets | $1.03B | +5.3% |
| Total Assets | $2.34B | +7.5% |
| Current Liabilities | $430.2M | -9.0% |
| Long-term Debt | $933.4M | +23.2% |
| Total Liabilities | $1.56B | +12.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $194.4M | -20.7% |
| Capital Expenditures | $74.3M | -0.4% |
| Investing Cash Flow | -$74.3M | +0.4% |
| Financing Cash Flow | -$124.8M | +30.5% |
| Free Cash Flow | $120.0M | -29.6% |
| -12.0% |
| EPS (Basic) | $3.13 | -7.4% |
| EPS (Diluted) | $3.11 | -7.7% |
| Stockholders' Equity |
| $783.6M |
| +2.4% |